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A 28-year-old man, a native of Morocco, was hospitalized
for acute renal failure associated with persistent vomiting.
The patient first presented at age 16 with cyclical episodes
of abdominal pain with vomiting, relieved transiently
by compulsive hot baths. He had continuously smoked
15 cigarettes and 5 cannabis ‘joints’ a day since the age of
14 years. He denied consumption of medication and other
illicit drugs or alcohol.
Table 1 shows serum studies during one of numerous
presentations. His liver function tests, amylase, and lipase
were normal. He was hospitalized five times during
2009–2010 with acute renal failure (Table 1). Urine sediment
was normal. Urinary (U) sodium was 53mmol/l, U
potassium 66mmol/l, U chloride o20mmol/l, U urea
500mmol/l, U protein o0.1 g/l, and U creatinine 12mmol/
l. Myoglobinuria was negative. Clinical examination was
suggestive of hypovolemia (tachycardia with orthostatic
hypotension). Colonoscopy and endoscopy of the upper
digestive tract were normal. He was treated with intravenous
fluids and antiemetic with spontaneous improvement of
symptoms, and the creatinine level dropped to a normal
value (75 mmol/l).
What is your diagnosis?
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Table 1 | Serum studies on patient at presentation
Sodium (135–145mmol/l) 133
Potassium (3.5–5.5mmol/l) 2.9
Chloride (97–105mmol/l) 70
Bicarbonates (23–30mmol/l) 40
Creatinine (40–120mmol/l) 398
Blood urea nitrogen (3–7mmol/l) 24
Protein (65–75 g/l) 90
Phosphorus (0.8–1.5mmol/l) 1.3
LDH (125–250UI) 567
CPK (10–180UI) 228
CRP (o10mg/l) 3
Uric acid (o240mmol/l) 560
pH (7.38–7.42) 7.69
CO2 (40–45mmHg) 33
PO2 (90–100mmHg) 100
Bicarbonates (25–28) 40
Hemoglobin (12.5–17 g/l) 17.1
Lactacidemia (o2.5mmol/l) 2.4
Abbreviations: CPK, creatinine phosphokinase; CRP, C-reactive protein; LDH, lactate
dehydrogenase.
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The Diagnosis | Cannabinoid hyperemesis syndrome
We made the diagnosis of cannabinoid hyperemesis syn-
drome associated with acute renal failure following intract-
able vomiting. Serum and urinary electrolytes status show
metabolic alkalosis, hemoconcentration, and extracellular
dehydration (Figure 1).
The patient was told that he had to quit smoking
cannabis, and we prescribed benzodiazepines for 1 week.
After discharge, he was subsequently hospitalized five
additional times, each time with reversible functional renal
failure shown in the figure. He failed to stop his marijuana
use despite several hospitalizations.
Cannabis is a highly consumed drug. Global annual
cannabis use prevalence is estimated between 2.9 and 4.3% of
the population aged 15–64 years. It is the third most
commonly used drug after tobacco and alcohol. Traditionally,
cannabinoids have been utilized for recreational purposes or
therapeutically as antiemetics; however, recent reports
suggest that chronic or ‘excessive’ use can result in a toxic
effect causing cyclic vomiting, which has been termed
‘cannabinoid hyperemesis syndrome’.1–3
The syndrome is characterized by a recurrent initial stage
with nausea and abdominal discomfort. Next, intractable
vomiting with thirst and polydypsia occurs. Sontineni and
colleagues suggest the following diagnostic criteria: history of
regular cannabis use for years, severe nausea and vomiting,
vomiting that recurs in a cyclic pattern over months, and
resolution of symptoms after stopping cannabis use,
supportive features are compulsive hot baths with symptom
relief (which ceases as soon as the sufferer stops bathing
with a total duration of bathing averages 5±5.1 h per day),
colicky abdominal pain, and no evidence of gall bladder or
pancreatic inflammation.1,4
Some patients lose more than 5 kg of weight. There is no
fever, and patients have no other demonstrable etiology for
vomiting. Abdominal ultrasounds as abdominal and cerebral
scan were always unremarkable. All patients obtain resolution
of their symptoms by cannabis cessation, while those who do
not quit continue to have this syndrome.5
It seems important to inform nephrologists about this
syndrome because of its frequency and the considerable
associated health-care costs. The syndrome is stereotyped and
can be easily recognized.
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Figure 1 |Description of recurrent episodes of acute renal
failure during a 1-year period. Arrows indicate each episode of
vomiting associated with compulsive hot-bath behavior. Every
episode resolves with restoration of extracellular volume.
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